Research paper

Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway

View original item

About this item

Title
Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway
Content partner
The University of Auckland Library
Collection
ResearchSpace@Auckland
Description

Renal fibrosis is a main cause of end-stage renal disease. Clinically, there is no beneficial treatment that can effectively reverse the progressive loss of renal function. We recently synthesized a novel proteolysis-resistant cyclic helix B peptide (CHBP) that exhibits promising renoprotective effects. In this study, we evaluated the effect of CHBP on renal fibrosis in an in vivo ischemia reperfusion injury (IRI) model and in vitro TGF-β-stimulated tubular epithelial cells (TCMK-1 and HK-2) ...

Format
Research paper
Research format
Journal article
Date created
2015-11
Creator
Yang, Cheng / Cao, Ye / Zhang, Yi / Li, Long / Xu, Ming / Long, Yaqiu / Rong, Ruiming / Zhu, Tongyu
URL
https://hdl.handle.net/2292/66176
Related subjects
Kidney / Animals / Mice, Inbred BALB C / Humans / Mice / Kidney Diseases / Reperfusion Injury / Fibrosis / Peptides, Cyclic / Transforming Growth Factor beta / Male / Proto-Oncogene Proteins c-akt / Forkhead Transcription Factors / Phosphatidylinositol 3-Kinases / Epithelial-Mesenchymal Transition / Forkhead Box Protein O3 / 32 Biomedical and Clinical Sciences / Kidney Disease / 1.1 Normal biological development and functioning / 1 Underpinning research / 2 Aetiology / 2.1 Biological and endogenous factors / Science & Technology / Life Sciences & Biomedicine / Medicine, Research & Experimental / Research & Experimental Medicine / Cyclic helix B peptide / Renal ischemia reperfusion injury / Akt / FoxO3 / NAKED CASPASE-3 SIRNA / ACUTE KIDNEY INJURY / ISCHEMIA/REPERFUSION INJURY / AUTOTRANSPLANT KIDNEYS / INFLAMMATION / ACTIVATION / DISEASE / MODEL / 11 Medical and Health Sciences / 42 Health sciences

What can I do with this item?

Check copyright status and what you can do with this item

Check information

Report this item

If you believe this item breaches our terms of use please report this item

Report this item

DigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 08 October 2023, and updated 12 April 2024.
Learn more about how we work.

Share

What can I do with this item?

You must always check with The University of Auckland Library to confirm the specific terms of use, but this is our understanding:

Research icon

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it icon

Share it

This item is suitable for copying and sharing with others, without further permission.

This item is suitable for copying and sharing with others, without further permission.

Modify it icon

Modify it

This item is suitable for modifying, remixing and building upon, without further permission.

This item is suitable for modifying, remixing and building upon, without further permission.

Use it commercially icon

Use it commercially

This item is suitable for commercial use, without further permission.

This item is suitable for commercial use, without further permission.

View original item

What can I do with this item?

Check copyright status and what you can do with this item

Check information

Report this item

If you believe this item breaches our terms of use please report this item

Report this item

DigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 08 October 2023, and updated 12 April 2024.
Learn more about how we work.

Share

Related items

Loading...